leadf
logo-loader
viewSEED Innovations Ltd
(
AIM:SEED
)

FastForward Innovations’ EMMAC Life Sciences selected as supplier for French medical cannabis trial

The trial, the first of its kind in France, will allow 3,000 patients access to medical cannabis as a treatment option for certain ailments including chronic pain, epilepsy, oncology and spasticity under tightly controlled conditions

FastForward Innovations Limited - FastForward Innovations’ EMMAC Life Sciences selected as supplier for French medical cannabis trial

FastForward Innovations Ltd (LON:FFWD) has said its portfolio company EMMAC Life Sciences, in which it holds a 2.3% stake, has been selected as a supplier for an upcoming medical cannabis trial in France through its partnership with homoeopathic products maker Boiron.

In an announcement late on Tuesday afternoon, EMMAC said the trial, the first of its kind in France, will allow 3,000 patients access to medical cannabis as a treatment option for certain ailments including chronic pain, epilepsy, oncology and spasticity under tightly controlled conditions.

READ: FastForward Innovations delighted at Yooma merger approval

The company said the French Agency for the Safety of Medicines and Health Products (ANSM) has selected EMMAC’s 20/1 and 10/10 oral solutions as second-source treatments which will be available to patients and healthcare professionals as part of the two-year trial.

It added that the partnership will combine Boiron’s expertise in plant-based medicine with EMMAC’s “uniquely controlled European supply chain” to deliver pharmaceutical-grade cannabis medicines that “meet the strict requirements of product quality, safety and traceability”.

"We are proud to have been selected to be part of this important trial.  Alongside Boiron, we are pleased to share our international experience to advance the industry's understanding of the benefits of medical cannabis”, EMMAC chief executive Antonio Costanzo said in a statement.

“The selection of our products by ANSM is testament to EMMAC's scientific knowledge and rigour, as well as our ability to provide products to the highest standards of compliance, safety and quality", he added.

Quick facts: SEED Innovations Ltd

Follow
AIM:SEED

Price: 7.2 GBX

Market Cap: £15.32 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Seed Innovations is committed to living better for longer and healthy...

So what’s in a name and a memorable ticker? Fast Forward Innovations has rebranded into Seed Innovations Limited (LON:SEED), and the business proposition is investment in emerging global health trends and the generation of attractive investment returns. Chief executive Ed McDermott tells...

on 21/7/21

2 min read